Back to Search
Start Over
The use of genomics in microbial vaccine development
- Source :
- Drug Discovery Today
- Publication Year :
- 2009
- Publisher :
- Elsevier BV, 2009.
-
Abstract
- Vaccination is one of the most effective tools for the prevention of infectious diseases. The availability of complete genome sequences, together with the progression of high-throughput technologies such as functional and structural genomics, has led to a new paradigm in vaccine development. Pan-genomic reverse vaccinology, with the comparison of sequence data from multiple isolates of the same species of a pathogen, increases the opportunity of the identification of novel vaccine candidates. Overall, the conventional empiric approach to vaccine development is being replaced by vaccine design. The recent development of synthetic genomics may provide a further opportunity to design vaccines.
- Subjects :
- Protozoan Vaccines
Molecular Sequence Data
Genomics
Genome, Viral
Biology
Communicable Diseases
Genome
Article
Structural genomics
Data sequences
Drug Discovery
Animals
Humans
Pharmacology
business.industry
Reverse vaccinology
Viral Vaccines
Biotechnology
Vaccination
Synthetic genomics
Drug Design
Bacterial Vaccines
Identification (biology)
business
Genome, Protozoan
Genome, Bacterial
Subjects
Details
- ISSN :
- 13596446
- Volume :
- 14
- Database :
- OpenAIRE
- Journal :
- Drug Discovery Today
- Accession number :
- edsair.doi.dedup.....bf480bf1f3bd527c15917029c7ecb148
- Full Text :
- https://doi.org/10.1016/j.drudis.2008.12.007